Cantor Fitzgerald Reiterates “Neutral” Rating for Acadia Healthcare (NASDAQ:ACHC)

Acadia Healthcare (NASDAQ:ACHC)‘s stock had its “neutral” rating reissued by research analysts at Cantor Fitzgerald in a report issued on Thursday, Benzinga reports. They currently have a $90.00 price objective on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 22.40% from the stock’s previous close.

Other research analysts also recently issued reports about the company. TD Cowen lowered their target price on Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating for the company in a research report on Friday, May 17th. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Wednesday, May 22nd. Bank of America lowered their target price on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, May 21st. Finally, Barclays decreased their price target on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating on the stock in a report on Thursday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $86.89.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC traded up $8.68 during mid-day trading on Thursday, reaching $73.53. 1,451,610 shares of the company traded hands, compared to its average volume of 766,599. The company’s 50 day moving average price is $66.89 and its 200-day moving average price is $73.92. The firm has a market cap of $6.82 billion, a PE ratio of -525.18, a PEG ratio of 2.01 and a beta of 1.31. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. Acadia Healthcare has a 52 week low of $62.04 and a 52 week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. During the same period in the prior year, the company posted $0.92 EPS. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities analysts expect that Acadia Healthcare will post 3.51 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in ACHC. Avidity Partners Management LP grew its position in shares of Acadia Healthcare by 61.8% during the 4th quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after buying an additional 441,692 shares in the last quarter. Sea Cliff Partners Management LP bought a new position in shares of Acadia Healthcare during the 4th quarter worth $26,338,000. Vaughan Nelson Investment Management L.P. bought a new position in shares of Acadia Healthcare during the 4th quarter worth $24,157,000. Jennison Associates LLC grew its position in shares of Acadia Healthcare by 26.1% during the 4th quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock worth $89,327,000 after buying an additional 238,114 shares in the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of Acadia Healthcare by 59.3% during the 1st quarter. Principal Financial Group Inc. now owns 539,162 shares of the company’s stock worth $42,712,000 after buying an additional 200,765 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.